Roflumilast ameliorates cognitive impairment in APP/PS1 mice via cAMP/CREB/BDNF signaling and anti-neuroinflammatory effects
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Roflumilast ameliorates cognitive impairment in APP/PS1 mice via cAMP/CREB/BDNF signaling and anti-neuroinflammatory effects
Authors
Keywords
Roflumilast, Phosphodiesterase-4, Alzheimer’s disease, cAMP-response element binding protein (CREB), Neuroinflammation, Cognition
Journal
METABOLIC BRAIN DISEASE
Volume -, Issue -, Pages -
Publisher
Springer Nature
Online
2019-01-05
DOI
10.1007/s11011-018-0374-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Acute administration of roflumilast enhances immediate recall of verbal word memory in healthy young adults
- (2018) M.A. Van Duinen et al. NEUROPHARMACOLOGY
- Cyclic AMP Pathway Suppress Autoimmune Neuroinflammation by Inhibiting Functions of Encephalitogenic CD4 T Cells and Enhancing M2 Macrophage Polarization at the Site of Inflammation
- (2018) Tatyana Veremeyko et al. Frontiers in Immunology
- Neuroinflammatory responses in Alzheimer’s disease
- (2017) Cira Dansokho et al. JOURNAL OF NEURAL TRANSMISSION
- FFPM, a PDE4 inhibitor, reverses learning and memory deficits in APP/PS1 transgenic mice via cAMP/PKA/CREB signaling and anti-inflammatory effects
- (2017) Haibiao Guo et al. NEUROPHARMACOLOGY
- The PDE4 inhibitor roflumilast improves memory in rodents at non-emetic doses
- (2016) Tim Vanmierlo et al. BEHAVIOURAL BRAIN RESEARCH
- Effects of rolipram and roflumilast, phosphodiesterase-4 inhibitors, on hypertension-induced defects in memory function in rats
- (2015) Sobhana George Sugin Lal Jabaris et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Neuroinflammatory Signals in Alzheimer Disease and APP/PS1 Transgenic Mice
- (2015) Irene López-González et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- Amyloid cascade hypothesis: Pathogenesis and therapeutic strategies in Alzheimer's disease
- (2015) Sagar H. Barage et al. NEUROPEPTIDES
- Donepezil improves learning and memory deficits in APP/PS1 mice by inhibition of microglial activation
- (2015) H.B. Guo et al. NEUROSCIENCE
- Apremilast: First Global Approval
- (2014) Raewyn M. Poole et al. DRUGS
- A Positive Autoregulatory BDNF Feedback Loop via C/EBP Mediates Hippocampal Memory Consolidation
- (2014) D. Bambah-Mukku et al. JOURNAL OF NEUROSCIENCE
- Improvement of spatial memory function in APPswe/PS1dE9 mice after chronic inhibition of phosphodiesterase type 4D
- (2013) A.S.R. Sierksma et al. NEUROPHARMACOLOGY
- Comprehensive behavioral characterization of an APP/PS-1 double knock-in mouse model of Alzheimer's disease
- (2013) Scott J Webster et al. Alzheimers Research & Therapy
- Phosphodiesterases as Therapeutic Targets for Alzheimer's Disease
- (2012) Ana García-Osta et al. ACS Chemical Neuroscience
- Roflumilast: A Phosphodiesterase-4 Inhibitor for the Treatment of Severe Chronic Obstructive Pulmonary Disease
- (2012) Nathan A. Pinner et al. CLINICAL THERAPEUTICS
- Characterization of cognitive deficits in a transgenic mouse model of Alzheimer's disease and effects of donepezil and memantine
- (2012) Akira Nagakura et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Zymosan activates protein kinase A via adenylyl cyclase VII to modulate innate immune responses during inflammation
- (2012) Lily I. Jiang et al. MOLECULAR IMMUNOLOGY
- Neoechinulin A suppresses amyloid-β oligomer-induced microglia activation and thereby protects PC-12 cells from inflammation-mediated toxicity
- (2012) Pradeep Dewapriya et al. NEUROTOXICOLOGY
- ‘PUFA–GPR40–CREB signaling’ hypothesis for the adult primate neurogenesis
- (2012) Tetsumori Yamashima PROGRESS IN LIPID RESEARCH
- The molecular biology of memory: cAMP, PKA, CRE, CREB-1, CREB-2, and CPEB
- (2012) Eric R Kandel Molecular Brain
- Epigenetic Mechanisms in Alzheimer's Disease
- (2011) M. Daniilidou et al. CURRENT MEDICINAL CHEMISTRY
- The phosphodiesterase-4 inhibitor rolipram reverses Aβ-induced cognitive impairment and neuroinflammatory and apoptotic responses in rats
- (2011) Chuang Wang et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics
- (2011) Eric Karran et al. NATURE REVIEWS DRUG DISCOVERY
- Cognitive impairment in humanized APP×PS1 mice is linked to Aβ1–42 and NOX activation
- (2011) Annadora J. Bruce-Keller et al. NEUROBIOLOGY OF DISEASE
- Aβ plaque-associated glial reaction as a determinant of apoptotic neuronal death and cortical gliogenesis: A study in APP mutant mice
- (2011) Ilaria Luccarini et al. NEUROSCIENCE LETTERS
- Alzheimer’s Disease Pathologic Cascades: Who Comes First, What Drives What
- (2011) Russell H. Swerdlow NEUROTOXICITY RESEARCH
- The role of CREB signaling in Alzheimer’s disease and other cognitive disorders
- (2011) Carlos A. Saura et al. REVIEWS IN THE NEUROSCIENCES
- Targeting CREB signalling in neurogenesis
- (2010) Sebastian Dworkin et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Quantitative comparison of phosphodiesterase mRNA distribution in human brain and peripheral tissues
- (2010) Viktor Lakics et al. NEUROPHARMACOLOGY
- Tripchlorolide protects neuronal cells from microglia-mediated β-amyloid neurotoxicity through inhibiting NF-κB and JNK signaling
- (2009) Xiao-Dong Pan et al. GLIA
- Reversal of long-term dendritic spine alterations in Alzheimer disease models
- (2009) D. L. Smith et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started